Genpact Limited (NYSE:G) went up by 0.55% from its latest closing price compared to the recent 1-year high of $44.83. The company’s stock price has collected 3.32% of gains in the last five trading sessions. Press Release reported on 04/05/21 that Genpact Schedules Earnings Release and Conference Call for First Quarter 2021 Results
Is It Worth Investing in Genpact Limited (NYSE :G) Right Now?
Genpact Limited (NYSE:G) scored a price-to-earnings ratio above its average ratio, recording 27.98 x from its present earnings ratio. Plus, the 36-month beta value for G is at 1.40. Opinions of the stock are interesting as 6 analysts out of 10 who provided ratings for Genpact Limited declared the stock was a “buy,” while 1 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $48.78, which is $4.14 above the current price. G currently public float of 175.29M and currently shorts hold a 2.03% ratio of that float. Today, the average trading volume of G was 1.23M shares.
G’s Market Performance
G stocks went up by 3.32% for the week, with a monthly jump of 5.91% and a quarterly performance of 7.46%, while its annual performance rate touched 59.83%. The volatility ratio for the week stands at 1.60% while the volatility levels for the past 30 days are set at 1.94% for Genpact Limited. The simple moving average for the period of the last 20 days is 2.00% for G stocks with a simple moving average of 10.45% for the last 200 days.
Analysts’ Opinion of G
Many brokerage firms have already submitted their reports for G stocks, with Needham repeating the rating for G by listing it as a “Buy.” The predicted price for G in the upcoming period, according to Needham is $45 based on the research report published on November 03rd of the previous year 2020.
Needham, on the other hand, stated in their research note that they expect to see G reach a price target of $40, previously predicting the price at $36. The rating they have provided for G stocks is “Buy” according to the report published on May 12th, 2020.
JP Morgan gave a rating of “Overweight” to G, setting the target price at $39 in the report published on April 14th of the previous year.
G Trading at 5.84% from the 50-Day Moving Average
After a stumble in the market that brought G to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -1.32% of loss for the given period.
Volatility was left at 1.94%, however, over the last 30 days, the volatility rate increased by 1.60%, as shares surge +4.12% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.72% upper at present.
During the last 5 trading sessions, G rose by +3.32%, which changed the moving average for the period of 200-days by +24.83% in comparison to the 20-day moving average, which settled at $43.46. In addition, Genpact Limited saw 6.96% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at G starting from Kalra Balkrishan, who sale 1,000 shares at the price of $42.80 back on Mar 12. After this action, Kalra Balkrishan now owns 187,268 shares of Genpact Limited, valued at $42,800 using the latest closing price.
Kalra Balkrishan, the Senior Vice President of Genpact Limited, sale 1,000 shares at $42.72 during a trade that took place back on Mar 11, which means that Kalra Balkrishan is holding 163,823 shares at $42,718 based on the most recent closing price.
Stock Fundamentals for G
Current profitability levels for the company are sitting at:
- +12.89 for the present operating margin
- +34.10 for the gross margin
The net margin for Genpact Limited stands at +8.32. The total capital return value is set at 13.01, while invested capital returns managed to touch 9.05. Equity return is now at value 18.00, with 6.50 for asset returns.
Based on Genpact Limited (G), the company’s capital structure generated 108.26 points at debt to equity in total, while total debt to capital is 51.98. Total debt to assets is 40.75, with long-term debt to equity ratio resting at 88.74. Finally, the long-term debt to capital ratio is 42.61.
When we switch over and look at the enterprise to sales, we see a ratio of 2.54, with the company’s debt to enterprise value settled at 0.21. The receivables turnover for the company is 4.05 and the total asset turnover is 0.79. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.45.